Agile Lied About Birth Control Patch Study, Investor Says
Agile Therapeutics Inc. misled investors into thinking that a contraceptive patch it was developing would get U.S. Food and Drug Administration approval, even though more than half the participants had dropped...To view the full article, register now.
Already a subscriber? Click here to view full article